Home
Menu

CME-CPD

Educational objectives

After participating in this educational activity, participants should be able to:

  • Describe key aspects of pain practice management, including billing, authorization, workflow standardization (e.g., staff education, sedation policies, template building), and payer considerations.
  • Summarize current best practices in interventional pain procedures, including fundamentals of surgical skills (suturing, infection control, wound management) and advanced interventional techniques (e.g., RFA, spinal cord stimulation, and cardiac device management).
  • Discuss regulatory and administrative considerations relevant to independent pain practice, including state-level Local Coverage Determinations (LCDs) and other payer-specific policies.
  • Apply practice management principles to develop efficient, patient-centered clinic workflows, improving scheduling, patient access, and staff utilization.
  • Demonstrate procedural competence through participation in hands-on workshops and advanced interventional procedures.
  • Interpret and apply LCDs, coding, and billing practices specific to participants’ regions to optimize practice revenue and compliance.
  • Implement evidence-based practice protocols and integrate them into daily pain management activities.
  • Establish and participate in mentorship networks, engaging in structured discussions on clinical practice challenges and solutions relevant to early-career pain physicians.
  • Assess and improve one’s own practice using course-provided tools (e.g., practice management portfolio) and feedback from mentors and peers.

Target audience 

This certificate program is designed for physicians 0-5 years post pain fellowship; specifically for pain practitioners, anesthesiologists, physiatrists, neurologists, and other physicians practicing in pain medicine looking to expand their knowledge in clinical areas and practice management. 

Methods of Participation

  • 12 CME credit hours will be comprised of asynchronous online learning activities 
  •  An additional 4 CME credit hours will be focused on practice management content (may be live or asynchronous)
  • 4 CME credit hours will consist of in-person procedural workshops (earned through attendance at the ASRA Pain Medicine Meeting or another preapproved activity; additional fees may apply).

Accreditation and credit designation statements 

Available Credit
16 AMA PRA Category 1 Credits™

Physicians
The American Society of Regional Anesthesia and Pain Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Society of Regional Anesthesia and Pain Medicine designates this Other activity (asynchronous online program) for a maximum of 16.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Learners
ASRA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

The American Board of Anesthesiology® MOCA®

This activity contributes to the CME requirements for Part II: Lifelong Learning and Self-Assessment of the American Board of Anesthesiology’s (ABA) redesigned Maintenance of Certification in Anesthesiology Program® (MOCA®), known as MOCA 2.0™. Please consult the ABA website, www.theABA.org, for a list of all MOCA 2.0 requirements. Maintenance of Certification in Anesthesiology Program® and MOCA® are registered certification marks of The American Board of Anesthesiology®.

ASRA Pain Medicine is an ABA-approved provider and, as a service to ASRA Pain Medicine members and participants, CME credits are reported to the ABA. Participants must include their correctly formatted ABA ID number (34567890) during the online evaluation and credit claim process available at the conclusion of the activity. Once the online evaluation and credit claim process is closed, certificates will be issued and credits reported to the ABA. After this time, participants may request their CME certificate by contacting [email protected], but ASRA Pain Medicine will no longer report credits to the ABA, which will then be the individual participant’s responsibility.

International credits

Royal College of Physicians and Surgeons of Canada
The Royal College of Physicians and Surgeons of Canada has agreements based on the mutual recognition of credit points with the American Medical Association for live and web-based (synchronous or asynchronous) educational events.  You may submit your CME certificate directly for credit recognition of this accredited group learning activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada. For more information, visit: www.royalcollege.ca.

European Accreditation Council for Continuing Medical Education (UEMS-EACCME)
The UEMS-EACCME has agreements based on the mutual recognition of credit points with the American Medical Association for live and e-learning educational events. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. The EACCME is an institution of the European Union of Medical Specialists (UEMS): www.uems.net.

Commercial support disclosure

No industry support has been received for this educational activity.

Disclosure and mitigation of personal conflicts of interest

View faculty disclosures (coming soon). In accordance with the ACCME’s Standards of Integrity and Independence and related policies, ASRA Pain Medicine is committed to ensuring balance, independence, objectivity, and scientific rigor in its CME/CPD activities. Those in control of the educational content must disclose all relationships (financial or other) with any ineligible company that they have had within the past 24 months. If an individual refuses to disclose, they are disqualified from participating. Disclosure information is evaluated to determine relevance and any conflicts of interest mitigated. Disclosure of all relevant financial relationships with ineligible companies is made to participants prior to the activity. Participants are asked to evaluate the objectivity and independence. Off-label or investigational use of a therapeutic product is also disclosed.